D. pteronyssinus-tyrosine adsorbate: biological and clinical properties.
Adsorption of D. pteronyssinus on tyrosine gives a depot formulation with retained immunogenicity. Preliminary clinical evaluation of this material showed improvement in the majority of allergic subjects after receipt of the initial six doses, improvement being continued during subsequent maintenance therapy.
D000327:Adsorption; D000485:Allergens / Q000302:isolation & purification; D000818:Animals; D001249:Asthma / Q000628:therapy*; D003888:Desensitization, Immunologic / Q000379:methods; D006168:Guinea Pigs; D006801:Humans; D008925:Mites / Q000276:immunology*; D012130:Respiratory Hypersensitivity / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy; D012882:Skin Tests; D014443:Tyrosine
D000485:Allergens; D014443:Tyrosine